KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Adaptive Biotechnologies (ADPT) Return on Equity (2019 - 2025)

Adaptive Biotechnologies' Return on Equity history spans 7 years, with the latest figure at 0.27% for Q4 2025.

  • For Q4 2025, Return on Equity rose 48.0% year-over-year to 0.27%; the TTM value through Dec 2025 reached 0.27%, up 48.0%, while the annual FY2025 figure was 0.28%, 35.0% up from the prior year.
  • Return on Equity for Q4 2025 was 0.27% at Adaptive Biotechnologies, up from 0.41% in the prior quarter.
  • Across five years, Return on Equity topped out at 0.21% in Q1 2021 and bottomed at 0.84% in Q3 2024.
  • The 5-year median for Return on Equity is 0.44% (2022), against an average of 0.5%.
  • The largest annual shift saw Return on Equity tumbled -37bps in 2024 before it soared 48bps in 2025.
  • A 5-year view of Return on Equity shows it stood at 0.33% in 2021, then fell by -25bps to 0.41% in 2022, then plummeted by -63bps to 0.67% in 2023, then fell by -11bps to 0.75% in 2024, then surged by 64bps to 0.27% in 2025.
  • Per Business Quant, the three most recent readings for ADPT's Return on Equity are 0.27% (Q4 2025), 0.41% (Q3 2025), and 0.66% (Q2 2025).